2010
DOI: 10.1590/s1413-86702010000100014
|View full text |Cite
|
Sign up to set email alerts
|

Methicillin/Oxacillin-resistant Staphylococcus aureus as a hospital and public health threat in Brazil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
18
0
9

Year Published

2012
2012
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(29 citation statements)
references
References 60 publications
2
18
0
9
Order By: Relevance
“…Currently, S. aureus is one of the leading causes of healthcare-associated infection worldwide. Most importantly, a substantial proportion of staphylococcal infections are caused by methicillinresistant S. aureus (MRSA), which also exhibits resistance to several other antimicrobials [5,6], contributing to its persistence as a human pathogen for decades.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, S. aureus is one of the leading causes of healthcare-associated infection worldwide. Most importantly, a substantial proportion of staphylococcal infections are caused by methicillinresistant S. aureus (MRSA), which also exhibits resistance to several other antimicrobials [5,6], contributing to its persistence as a human pathogen for decades.…”
Section: Introductionmentioning
confidence: 99%
“…Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen throughout the world but in Brazil it accounts for more than half of all S. aureus isolates in most hospitals [1].…”
mentioning
confidence: 99%
“…Although moderate declining of hospital-acquired MRSA (HA-MRSA) bacteremia was recently observed in a few European countries, the United States and Australia [3][4][5], this pathogen is the most common single multidrug resistant (MDR) cause of HAIs in Europe, the United States, Asia, and Brazil [6][7][8][9]. The European/EEA population-mean of invasive HA-MRSA infections in 2013 was 18.0% [10]; however, these percentages vary greatly within a continent, from 0 in Iceland up to 64.5% in Romania, indicating major differences in epidemiology of MRSA bacteremia, while data from the non-EU states of the Balkan region remain underrepresented.…”
Section: Introductionmentioning
confidence: 99%